Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
Conditions
Interventions
Intervention1: Methylphenidate: Methylphenidate (0.3mg/kg twice a day ) administered orally in the form of tablets for 12 weeks
Control Intervention1: Omega-3 fatty acids: Omega-3 Fatty acids 1000mg p
Sponsors
Government Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age of the participant between 6-12 years. 2. Children who are willing to give assent and parents/guardians of the participants are willing to give informed consent for participation. 3. School going children 4. Intelligence quotient more than 85 5. Children who have not received Methylphenidate in the past.
Exclusion criteria
Exclusion criteria: 1. Children with Autism Spectrum Disorder. 2. Preexisting structural brain damage and seizures. 3. Presence co-morbid Conduct disorder, Anxiety disorder or Depressive disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the efficacy of omega 3 Fatty acids as an Adjuvant Therapy to Methylphenidate in Attention Deficit Hyperactivity DisorderTimepoint: Baseline, Week 1, Week 2, Week 4, End of week 8, End of Week 12 | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the efficacy of omega 3 Fatty acids as an Adjuvant Therapy to Methylphenidate in Attention Deficit Hyperactivity DisorderTimepoint: Baseline, Week 1, Week 2, Week 4, End of week 8, End of Week 12 | — |
Countries
India
Contacts
Public ContactDr Priti Arun
Government Medical college and Hospital
Outcome results
None listed